Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease.
Determining the degree of fibrosis is an important step in the assessment of disease severity in patients with chronic liver disease. Liver biopsy has been the gold standard for estimating the extent of inflammation and fibrosis, although the procedure has limitations such as sampling error and vari...
| Published in: | Gastroenterology & Hepatology Vol. 12; no. 1; pp. 33 - 41 |
|---|---|
| Main Authors: | , |
| Format: | pictorial protocol review tables/charts Journal Article |
| Published: |
Gastro-Hep Communications, Inc
Jan2016
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=112855259&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 112855259 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15547914 6N5B jtl: Gastroenterology & Hepatology issn: 15547914 maglogo: N pubinfo: dt: Jan2016 vid: 12 iid: 1 pid: 72163 pub: Gastro-Hep Communications, Inc place: New York, New York artinfo: ui: 112855259 112855259 112855259 112855259 ppf: 33 ppct: 8 formats: fmt: @attributes: type: P tig: atl: Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease. aug: au: Lucero, Catherine Brown Jr., Robert S. affil: assistant professor of medicine, Center for Liver Disease and Transplantation, Weill Cornell Medical Center, New York, New York sug: subj: Acoustics Hypertension, Portal Liver Diseases Sampling Error Functional Assessment Fibrosis ab: Determining the degree of fibrosis is an important step in the assessment of disease severity in patients with chronic liver disease. Liver biopsy has been the gold standard for estimating the extent of inflammation and fibrosis, although the procedure has limitations such as sampling error and variability. Noninvasive testing has been shown to be equally predictive in ruling out fibrosis or ruling in advanced fibrosis. Serum biomarkers and imaging-based tests have more limited predictive ability when classifying intermediate stages, but these tools can help identify which patients should receive antiviral treatment sooner and require ongoing cancer surveillance without the need for biopsy. Using a combination of serum markers and imaging tests may also be helpful in providing functional assessment of portal hypertension in patients with chronic liver disease. pubtype: Academic Journal doctype: pictorial protocol review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|